An exploration of Northern Ireland general practice pharmacists' views on their role in general practice: a cross-sectional survey.


Journal

BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676

Informations de publication

Date de publication:
06 Jun 2024
Historique:
received: 05 02 2024
accepted: 31 05 2024
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 6 6 2024
Statut: epublish

Résumé

There is limited research examining the views of general practice pharmacists (GPPs) on their role and their impact in general practice. The aim of this study was to explore GPPs' views regarding this role and its potential impact within general practice in Northern Ireland (NI). A paper-based self-administered questionnaire was mailed to 319 general practices in NI in 2022, directed to the GPP who spent most time at the practice. A variety of closed and open questions were included in six sections. Responses to closed questions were analysed descriptively whilst open question responses were analysed using content analysis. To ascertain associations between variables (e.g. GPP prescribing status, working arrangements and aspects of collaboration with GPPs), Fisher's exact test was employed with an a priori significance level of p < 0.05. 155 responses were received equating to a response rate of 48.5%. Most participants (72.3%) were female, independent prescribers (71%), and 64.5% were currently using their independent prescriber qualification. Services that were provided by most GPPs were medication reconciliation (99.4%) and medication reviews (97.4%). The most common method of communication between GPPs and general practitioners (GPs) was face-to-face (89.0%). Telephone was the most common method of communication between GPPs, community pharmacists (97.4%) and patients (98.7%). Most GPPs (> 80%) showed positive attitudes towards collaboration with GPs and those who worked in multiple practices were more likely to agree with the Attitudes Towards Collaboration Instrument for pharmacists (ATCI-P) statements compared to those who worked in a single practice (p < 0.05). Less than 40% (36.8%) of GPPs agreed that patients were aware of the role they provided. The majority of GPPs (80.6%) expressed positive views on their impact on primary care. Analysis of the free-text comments revealed the need for more GPP patient-facing activities, GPP-specific training, and promotion of the GPP role. The findings indicated that GPPs had largely positive views about their role and their impact on primary care. The results may be helpful for practices and service commissioners. Further research is necessary to explore the perspectives of patients regarding the role of the GPP and to enhance patients' awareness of the GPP.

Sections du résumé

BACKGROUND BACKGROUND
There is limited research examining the views of general practice pharmacists (GPPs) on their role and their impact in general practice. The aim of this study was to explore GPPs' views regarding this role and its potential impact within general practice in Northern Ireland (NI).
METHODS METHODS
A paper-based self-administered questionnaire was mailed to 319 general practices in NI in 2022, directed to the GPP who spent most time at the practice. A variety of closed and open questions were included in six sections. Responses to closed questions were analysed descriptively whilst open question responses were analysed using content analysis. To ascertain associations between variables (e.g. GPP prescribing status, working arrangements and aspects of collaboration with GPPs), Fisher's exact test was employed with an a priori significance level of p < 0.05.
RESULTS RESULTS
155 responses were received equating to a response rate of 48.5%. Most participants (72.3%) were female, independent prescribers (71%), and 64.5% were currently using their independent prescriber qualification. Services that were provided by most GPPs were medication reconciliation (99.4%) and medication reviews (97.4%). The most common method of communication between GPPs and general practitioners (GPs) was face-to-face (89.0%). Telephone was the most common method of communication between GPPs, community pharmacists (97.4%) and patients (98.7%). Most GPPs (> 80%) showed positive attitudes towards collaboration with GPs and those who worked in multiple practices were more likely to agree with the Attitudes Towards Collaboration Instrument for pharmacists (ATCI-P) statements compared to those who worked in a single practice (p < 0.05). Less than 40% (36.8%) of GPPs agreed that patients were aware of the role they provided. The majority of GPPs (80.6%) expressed positive views on their impact on primary care. Analysis of the free-text comments revealed the need for more GPP patient-facing activities, GPP-specific training, and promotion of the GPP role.
CONCLUSION CONCLUSIONS
The findings indicated that GPPs had largely positive views about their role and their impact on primary care. The results may be helpful for practices and service commissioners. Further research is necessary to explore the perspectives of patients regarding the role of the GPP and to enhance patients' awareness of the GPP.

Identifiants

pubmed: 38844848
doi: 10.1186/s12875-024-02457-7
pii: 10.1186/s12875-024-02457-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

201

Informations de copyright

© 2024. The Author(s).

Références

NHS England. Primary care services. 2016. https://www.england.nhs.uk/get-involved/get-involved/how/primarycare/ (Accessed: 5 Jan 2022).
Roland M, Guthrie B, Thomé DC. Primary medical care in the United Kingdom. J Am Board Fam Med. 2012;25(Suppl 1):S6–11.
doi: 10.3122/jabfm.2012.02.110200 pubmed: 22403251
British Medical Association. Workload Control in General Practice. 2018. Available from: https://www.bma.org.uk/media/1145/workload-control-general-practice-mar2018-1.pdf (Accessed: 5 Jan 2022).
Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, Ryan C, Hughes C. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9(9):CD008165.
pubmed: 30175841
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.
doi: 10.1186/s12877-017-0621-2 pubmed: 29017448 pmcid: 5635569
Kontopantelis E, Panagioti M, Farragher T, Munford LA, Parisi R, Planner C, Spooner S, Tse A, Ashcroft DM, Esmail A. Consultation patterns and frequent attenders in UK primary care from 2000 to 2019: a retrospective cohort analysis of consultation events across 845 general practices. BMJ Open. 2021;11(12):e054666.
doi: 10.1136/bmjopen-2021-054666 pubmed: 34930742 pmcid: 8718478
Mann C, Anderson C, Avery AJ, Waring J, Boyd M. Clinical Pharmacists in General Practice: Pilot Scheme: Independent Evaluation Report. 2018. https://www.nottingham.ac.uk/pharmacy/documents/generalpracticeyearfwdrev/clinical-pharmacists-in-general-practice-pilot-scheme-full-report.pdf (Accessed: 5 Dec 2021).
Department of Health. Minister announces investment to put pharmacists in GP practices. 2015. https://www.health-ni.gov.uk/news/minister-announces-investment-put-pharmacists-gp-practices (Accessed: 25 Jan 2022).
Hasan Ibrahim AS, Barry HE, Hughes CM. A systematic review of general practice-based pharmacists’ services to optimize medicines management in older people with multimorbidity and polypharmacy. Fam Pract. 2021;38(4):509–23.
doi: 10.1093/fampra/cmaa146 pubmed: 33506870
Savickas V, Foreman E, Ladva A, Bhamra SK, Sharma R, Corlett SA. Pharmacy services and role development in UK general practice: a cross-sectional survey. Int J Pharm Pract. 2021;29(1):37–44.
doi: 10.1111/ijpp.12653 pubmed: 32627272
National Health Service England. Clinical Pharmacists in General Practice Pilot FAQs. 2015. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/08/clin-pharm-gp-pilot-faqs-0815.pdf (Accessed: 25 Jan 2022).
National Health Service England. The NHS Long Term Plan. 2019. https://www.england.nhs.uk/wp-content/uploads/2019/01/gp-contract-2019.pdf (Accessed: 4 Dec 2021).
Health and Social Care Board. Investment in GP Practices. 2021. https://online.hscni.net/our-work/gps/investment-in-gp-practices/ (accessed 31 Jan 2022).
Strategic Leadership Group for Pharmacy. Practice-based pharmacists’ statement. 2016. https://www.health-ni.gov.uk/sites/default/files/publications/health/practice-based-pharmacists.pdf (accessed 25 Jan 2022).
Hasan Ibrahim AS, Barry HE, Hughes CM. General practitioners’ experiences with, views of, and attitudes towards, general practice-based pharmacists: a cross-sectional survey. BMC Prim Care. 2022;23(1):6.
doi: 10.1186/s12875-021-01607-5 pubmed: 35172734 pmcid: 8759266
Department of Health. Pharmacy Workforce Review. 2020. https://www.health-ni.gov.uk/publications/pharmacy-workforce-review-2020 (Accessed: 4 Jan 2022).
Sharma A, Minh Duc NT, Luu Lam Thang T, Nam NH, Ng SJ, Abbas KS, Huy NT, Marušić A, Paul CL, Kwok J, Karbwang J. A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med. 2021;36(10):3179–87.
doi: 10.1007/s11606-021-06737-1 pubmed: 33886027 pmcid: 8481359
Stewart D, Maclure K, Newham R, Gibson-Smith K, Bruce R, Cunningham S, Maclure A, Fry S, Mackerrow J, Bennie M. A cross-sectional survey of the pharmacy workforce in general practice in Scotland. Fam Pract. 2020;37(2):206–12.
pubmed: 31536620
Duncan P, Ridd MJ, McCahon D, Guthrie B, Cabral C. Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study. Br J Gen Pract. 2020;70(692):e155–63.
doi: 10.3399/bjgp20X708197 pubmed: 32041767 pmcid: 7015165
Butterworth J, Sansom A, Sims L, Healey M, Kingsland E, Campbell J. Pharmacists’ perceptions of their emerging general practice roles in UK primary care: a qualitative interview study. Br J Gen Pract. 2017;67(662):650–8.
doi: 10.3399/bjgp17X691733
Baker S, Lee YP, Hattingh HL. An evaluation of the role of practice pharmacists in Australia: a mixed methods study. Int J Clin Pharm. 2019;41(2):504–15.
doi: 10.1007/s11096-019-00807-5 pubmed: 30879214
Alshehri AA, Cheema E, Yahyouche A, Haque MS, Jalal Z. Evaluating the role and integration of general practice pharmacists in England: a cross-sectional study. Int J Clin Pharm. 2021;43(6):1609–18.
doi: 10.1007/s11096-021-01291-6 pubmed: 34080088 pmcid: 8642258
Barry HE, Clarke R, Hughes CM. Community pharmacists’ experiences with, views of, and attitudes towards general practice-based pharmacists: a cross-sectional survey study. Int J Pharm Pract. 2020;28(S1):31.
Van C, Costa D, Abbott P, Mitchell B, Krass I. Community pharmacist attitudes towards collaboration with general practitioners: development and validation of a measure and a model. BMC Health Serv Res. 2012;12:320.
doi: 10.1186/1472-6963-12-320 pubmed: 22978658 pmcid: 3507896
IBM Corp. IBM SPSS Statistics for Macintosh, Version 28.0. Armonk. NY: IBM Corp; Released 2021.
Stemler S. An overview of content analysis. Practical Assess Res Evaluation. 2001;7(1):17.
Cohen L, Manion L, Morrison K. Coding and content analysis. Research methods in education. Routledge; 2017. pp. 668–85.
Health and Social Care Board, Federations GP. 2023. https://online.hscni.net/our-work/gps/gp-federations/ (Accessed 20 Dec 2023).
Cardwell K, Smith SM, Clyne B, et al. Evaluation of the general practice pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study. BMJ Open. 2020;10:e035087.
doi: 10.1136/bmjopen-2019-035087 pubmed: 32595137 pmcid: 7322285
Zhou M, Desborough J, Parkinson A, Douglas K, McDonald D, Boom K. Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences. Int J Pharm Pract. 2019;27(6):479–89.
doi: 10.1111/ijpp.12557 pubmed: 31287208
Ahn J, Park JE, Anthony C, Burke M. Understanding, benefits and difficulties of home medicines review-patients’ perspectives. Aus Fam Physician. 2015;44(4):249–53.
Tan ECK, Stewart K, Elliott RA, George J. Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists. Int J Pharm Pract. 2014;22(1):28–37.
doi: 10.1111/ijpp.12047 pubmed: 23750666
Ryan K, Patel N, Lau WM, Abu-Elmagd H, Stretch G, Pinney H. Pharmacists in general practice: a qualitative interview case study of stakeholders’ experiences in a West London GP federation. BMC Health Serv Res. 2018;18(1):234.
doi: 10.1186/s12913-018-3056-3 pubmed: 29609603 pmcid: 5879559
Desborough JA, Twigg MJ. Pharmacist-led medication reviews in primary care. Rev Clin Gerontol. 2014;24(1):1–9.
doi: 10.1017/S0959259813000233
Bradley F, Seston E, Mannall C, Cutts C. Evolution of the general practice pharmacist’s role in England: a longitudinal study. Br J Gen Pract. 2018;68(675):727–34.
doi: 10.3399/bjgp18X698849
Karampatakis GD, Patel N, Stretch G, Ryan K. Community pharmacy teams’ experiences of general practice-based pharmacists: an exploratory qualitative study. BMC Health Serv Res. 2020;20(1):431.
doi: 10.1186/s12913-020-05245-y pubmed: 32423485 pmcid: 7236450
Sudeshika T, Naunton M, Peterson GM, Deeks LS, Guénette L, Sharma R, Freeman C, Niyonsenga T, Kosari S. Interprofessional collaboration and team effectiveness of pharmacists in general practice: a cross-national survey. Int J Environ Res Public Health. 2023;20(1):394.
doi: 10.3390/ijerph20010394
Deeks LS, Kosari S, Naunton M, Cooper G, Porritt J, Davey R, Dawda P, Goss J, Kyle G. Stakeholder perspectives about general practice pharmacists in the Australian Capital Territory: a qualitative pilot study. Aust J Prim. 2018;24(3):263–72.
doi: 10.1071/PY17086
Karampatakis GD, Patel N, Stretch G, Ryan K. Patients’ experiences of pharmacists in general practice: an exploratory qualitative study. BMC Fam Pract. 2021;22(1):48.
doi: 10.1186/s12875-021-01393-0 pubmed: 33673805 pmcid: 7935482
Sudeshika T, Naunton M, Yee KC, Deeks LS, Peterson GM, Kosari S. Patients’ opinions towards the services of pharmacists based in general practice. Pharmacy. 2022;10(4):78.
doi: 10.3390/pharmacy10040078 pubmed: 35893716 pmcid: 9326583
Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev. 2016;11(11):CD011227.
pubmed: 27873322
Jebara T, Cunningham S, MacLure K, Awaisu A, Pallivalapila A, Stewart D. Stakeholders’ views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018;84(9):1883–905.
doi: 10.1111/bcp.13624 pubmed: 29873098 pmcid: 6089831
Mann C, Anderson C, Boyd M. The role of clinical pharmacists in general practice in England: impact, perspectives, barriers and facilitators. Res Social Adm Pharm. 2022;18(8):3432–7.
doi: 10.1016/j.sapharm.2021.10.006
Kumar R. Research methodology: a step-by-step guide for beginners. 3rd ed. Los Angeles, SAGE; 2011.
Bresee LC. An introduction to developing surveys for pharmacy practice research. Can J Hosp Pharm. 2014;67(4):286–91.
pubmed: 25214660 pmcid: 4152968
Gnambs T, Kaspar K. Disclosure of sensitive behaviors across self-administered survey modes: a meta-analysis. Behav Res. 2015;47:1237–59.
doi: 10.3758/s13428-014-0533-4
Clark T, Foster L, Sloan L, Bryman A. Bryman’s social research methods. 6th ed. Oxford: Oxford University Press; 2021.

Auteurs

Abrar H F Hassan (AHF)

Primary Care Research Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.

Heather E Barry (HE)

Primary Care Research Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.

Carmel M Hughes (CM)

Primary Care Research Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK. c.hughes@qub.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH